Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure

• Published in: Proceedings of the National Academy of Sciences - PNAS 2017-01, Vol.114 (3), p.E386-E395
• Main Authors: Le Nouën, Cyril, McCarty, Thomas, Brown, Michael, Smith, Melissa Laird, Lleras, Roberto, Dolan, Michael A., Mehedi, Masfique, Yang, Lijuan, Luongo, Cindy, Liang, Bo, Munir, Shirin, DiNapoli, Joshua M., Mueller, Steffen, Wimmer, Eckard, Collins, Peter L., Buchholz, Ursula J.
• Format: Article
• Language: English
• Subjects: Biological Sciences; Genomes; Genotype & phenotype; PNAS Plus; Proteins; Respiratory syncytial virus; Risk assessment; Vaccines; Viruses
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.1619242114

Recoding viral genomes by numerous synonymous but suboptimal substitutions provides live attenuated vaccine candidates. These vaccine candidates should have a low risk of deattenuation because of the many changes involved. However, their genetic stability under selective pressure is largely unknown. We evaluated phenotypic reversion of deoptimized human respiratory syncytial virus (RSV) vaccine candidates in the context of strong selective pressure. Codon pair deoptimized (CPD) versions of RSV were attenuated and temperature-sensitive. During serial passage at progressively increasing temperature, a CPD RSV containing 2,692 synonymous mutations in 9 of 11 ORFs did not lose temperature sensitivity, remained genetically stable, and was restricted at temperatures of 34 °C/35 °C and above. However, a CPD RSV containing 1,378 synonymous mutations solely in the polymerase L ORF quickly lost substantial attenuation. Comprehensive sequence analysis of virus populations identified many different potentially deattenuating mutations in the L ORF as well as, surprisingly, many appearing in other ORFs. Phenotypic analysis revealed that either of two competing mutations in the virus transcription antitermination factor M2-1, outside of the CPD area, substantially reversed defective transcription of the CPD L gene and substantially restored virus fitness in vitro and in case of one of these two mutations, also in vivo. Paradoxically, the introduction into Min L of one mutation each in the M2-1, N, P, and L proteins resulted in a virus with increased attenuation in vivo but increased immunogenicity. Thus, in addition to providing insights on the adaptability of genome-scale deoptimized RNA viruses, stability studies can yield improved synthetic RNA virus vaccine candidates.